These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19136612)

  • 81. VE-PTP controls blood vessel development by balancing Tie-2 activity.
    Winderlich M; Keller L; Cagna G; Broermann A; Kamenyeva O; Kiefer F; Deutsch U; Nottebaum AF; Vestweber D
    J Cell Biol; 2009 May; 185(4):657-71. PubMed ID: 19451274
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Molecular controls of lymphatic VEGFR3 signaling.
    Deng Y; Zhang X; Simons M
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
    Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA
    J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
    Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
    J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Beyond VEGF: Angiopoietin-Tie Signaling Pathway in Diabetic Retinopathy.
    Chen-Li G; Martinez-Archer R; Coghi A; Roca JA; Rodriguez FJ; Acaba-Berrocal L; Berrocal MH; Wu L
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792322
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CD93 maintains endothelial barrier function and limits metastatic dissemination.
    Vemuri K; de Alves Pereira B; Fuenzalida P; Subashi Y; Barbera S; van Hooren L; Hedlund M; Pontén F; Lindskog C; Olsson AK; Lugano R; Dimberg A
    JCI Insight; 2024 Mar; 9(7):. PubMed ID: 38441970
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Heterogeneity of endothelial VE-PTP downstream polarization, Tie2 activation, junctional claudin-5, and permeability in the aorta and vena cava.
    Baluk P; Shirakura K; Vestweber D; McDonald DM
    Cell Tissue Res; 2024 Jan; 395(1):81-103. PubMed ID: 38032480
    [TBL] [Abstract][Full Text] [Related]  

  • 88. An agonistic anti-Tie2 antibody suppresses the normal-to-tumor vascular transition in the glioblastoma invasion zone.
    Lee E; Lee EA; Kong E; Chon H; Llaiqui-Condori M; Park CH; Park BY; Kang NR; Yoo JS; Lee HS; Kim HS; Park SH; Choi SW; Vestweber D; Lee JH; Kim P; Lee WS; Kim I
    Exp Mol Med; 2023 Feb; 55(2):470-484. PubMed ID: 36828931
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Shear stress control of vascular leaks and atheromas through Tie2 activation by VE-PTP sequestration.
    Shirakura K; Baluk P; Nottebaum AF; Ipe U; Peters KG; McDonald DM; Vestweber D
    EMBO Mol Med; 2023 Apr; 15(4):e16128. PubMed ID: 36740996
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Extracellular Vesicles from Human Umbilical Cord-Derived MSCs Affect Vessel Formation In Vitro and Promote VEGFR2-Mediated Cell Survival.
    Muñiz-García A; Wilm B; Murray P; Cross MJ
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497011
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Actin cytoskeleton in angiogenesis.
    Yadunandanan Nair N; Samuel V; Ramesh L; Marib A; David DT; Sundararaman A
    Biol Open; 2022 Dec; 11(12):. PubMed ID: 36444960
    [TBL] [Abstract][Full Text] [Related]  

  • 92. β
    Kwak EA; Pan CC; Ramonett A; Kumar S; Cruz-Flores P; Ahmed T; Ortiz HR; Lochhead JJ; Ellis NA; Mouneimne G; Georgieva TG; Lee YS; Vanderah TW; Largent-Milnes T; Mohler PJ; Hund TJ; Langlais PR; Mythreye K; Lee NY
    Nat Commun; 2022 Mar; 13(1):1326. PubMed ID: 35288568
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Single-Cell Transcriptomics Reveal Disrupted Kidney Filter Cell-Cell Interactions after Early and Selective Podocyte Injury.
    Clark AR; Marshall J; Zhou Y; Montesinos MS; Chen H; Nguyen L; Chen F; Greka A
    Am J Pathol; 2022 Feb; 192(2):281-294. PubMed ID: 34861215
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    Luo H; Zhang Y; Deng Y; Li L; Sheng Z; Yu Y; Lin Y; Chen X; Feng P
    Front Cell Dev Biol; 2021; 9():728821. PubMed ID: 34733844
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Growth Factor Deregulation and Emerging Role of Phosphatases in Diabetic Peripheral Artery Disease.
    Mercier C; Rousseau M; Geraldes P
    Front Cardiovasc Med; 2020; 7():619612. PubMed ID: 33490120
    [TBL] [Abstract][Full Text] [Related]  

  • 96. PRL-2 phosphatase is required for vascular morphogenesis and angiogenic signaling.
    Poulet M; Sirois J; Boyé K; Uetani N; Hardy S; Daubon T; Dubrac A; Tremblay ML; Bikfalvi A
    Commun Biol; 2020 Oct; 3(1):603. PubMed ID: 33097786
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.
    Machado I; Giner F; Lavernia J; Cruz J; Traves V; Requena C; Llombart B; López-Guerrero JA; Llombart-Bosch A
    Histol Histopathol; 2021 Jan; 36(1):3-18. PubMed ID: 32885407
    [TBL] [Abstract][Full Text] [Related]  

  • 98. WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade.
    Huang SW; Yang HY; Huang WJ; Chen WC; Yu MC; Wang SW; Hsu YF; Hsu MJ
    Front Oncol; 2019; 9():1188. PubMed ID: 31781495
    [No Abstract]   [Full Text] [Related]  

  • 99. Disrupting the transmembrane domain-mediated oligomerization of protein tyrosine phosphatase receptor J inhibits EGFR-driven cancer cell phenotypes.
    Bloch E; Sikorski EL; Pontoriero D; Day EK; Berger BW; Lazzara MJ; Thévenin D
    J Biol Chem; 2019 Dec; 294(49):18796-18806. PubMed ID: 31676686
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Targeting the vascular-specific phosphatase PTPRB protects against retinal ganglion cell loss in a pre-clinical model of glaucoma.
    Thomson BR; Carota IA; Souma T; Soman S; Vestweber D; Quaggin SE
    Elife; 2019 Oct; 8():. PubMed ID: 31621585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.